Recurrent COVID-19 Infection in a Refractory/Classical Hodgkin's Lymphoma Patient Undergoing Autologous Stem Cell Transplantation: A Case Report

Patients with challenging hematological malignancies like classic Hodgkin lymphoma (cHL) can be further complicated when affected by a concurrent coronavirus disease-2019 (COVID-19) infection and often face unique and complex management and outcomes. In this case report, we describe a refractory or...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamed, Munerah, Alamoudi, Doaa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10640764/
https://www.ncbi.nlm.nih.gov/pubmed/38022277
http://dx.doi.org/10.7759/cureus.46950

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10640764/
https://www.ncbi.nlm.nih.gov/pubmed/38022277
http://dx.doi.org/10.7759/cureus.46950

Ejemplares similares